Peptide Brands Face Harsh Google Ads Enforcement
The Google Ads policy for peptide brands is complex and heavily enforced, making it challenging for advertisers to navigate. According to Oney Studio, a team that has successfully run peptide ads for over two years, most accounts get flagged or suspended within the first 90 days without proper setup.
The category is not banned, but it's considered regulated due to its intersection with three existing policy areas: healthcare and medicines, unapproved substances, and dangerous products. Google's enforcement in this category is primarily algorithmic, meaning ads are scanned by automated systems that match patterns in copy, landing page content, and keyword context against enforcement criteria.
The team has identified four common failure patterns that get peptide ad accounts flagged: using specific compound names in headlines, mechanism-of-action language in ad copy, landing pages that pass visual review but fail algorithmic scanning, and building account history with policy strikes in the early phase. To build a compliant peptide ad account from scratch, Oney Studio recommends creating a compliance foundation before launch, including auditing landing page and product copy, mapping keyword architecture to enforcement risk, and developing ad copy against enforcement logic.